MRI靶向穿刺时代减少系统穿刺针数对临床显著性前列腺癌检出及局灶治疗规划的影响
回顾性分析398例接受系统饱和穿刺(约24针)联合MRI-US融合靶向穿刺的男性,建模四种减少系统穿刺针数的策略(三分之二、一半、三分之一、四分之一),比较临床显著性前列腺癌(csPCa,分级组≥2)检出率及局灶治疗计划改变比例。减少系统穿刺针数使csPCa检出率显著降低,且改变局灶治疗计划的比例随针数减少而增加。
要点
- csPCa总体检出率为42%(168/398),非靶向系统饱和穿刺csPCa检出率为21%(83/398)。
- 减少系统穿刺针数后csPCa检出率分别降至16%、13%、9%、8%(均p < 0.05)。
- 与减少针数策略相比,全系统饱和穿刺改变局灶治疗计划的比例分别为12%(2/3针)、19%(1/2针)、24%(1/3针)、29%(1/4针)(p = 0.0434)。
核心结论
- 在MRI靶向穿刺时减少系统穿刺针数会导致csPCa检出率降低并改变局灶治疗计划,可能限制其肿瘤学疗效。
研究设计与样本
- 回顾性分析398例连续接受系统饱和穿刺(约24针)和MRI-US融合靶向穿刺的男性。
主要发现
- csPCa在该队列中检出率为42%(168/398),非靶向系统饱和穿刺的csPCa检出率为21%(83/398)。
- 四种减少针数策略将非靶向系统穿刺平均针数从21.8分别降至14.5、10.9、7.3和5.4针。
- 对应的csPCa检出率分别显著降至16%、13%、9%和8%(均p < 0.05)。
- 与减少针数策略相比,全系统饱和穿刺导致局灶治疗计划改变的比例分别为12%(2/3针)、19%(1/2针)、24%(1/3针)和29%(1/4针)(p = 0.0434)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The optimal number of systematic biopsy cores in the era of multi-parametric MRI targeted biopsy remains unclear, especially on its impact of focal therapy planning. Our objective is to investigate the impact of reducing the number of systematic cores on prostate cancer detection in the era of MRI-US fusion targeted biopsy and as well as its relevance in template planning for focal therapy. MATERIALS AND METHODS: A retrospective analysis of 398 consecutive men who underwent both systematic saturation (~24 cores) and MRI-US fusion targeted biopsy was performed. Four reduced-core systematic biopsy strategies (two-thirds, half, one-third and one-quarter systematic cores) were modelled and the detection rates of clinically-significant prostate cancer (csPCa defined as grade group ≥2) were compared to that of a full systematic biopsy using McNemar's test. Focal therapy treatment plans were made based on positive cores on combined (targeted and systematic) biopsy and the various reduced-cores strategies to compare the proportion who had a change in treatment plan. RESULTS: csPCa was detected in 42% (168/398) of this patient cohort. Non-targeted systematic saturation biopsy had a 21% (83/398) csPCa detection rate. Our four strategies reduced the mean number of non-targeted systematic cores from 21.8 to 14.5, 10.9, 7.3 and 5.4 cores and their csPCa detection rates were significantly decreased to 16%, 13%, 9% and 8% respectively (all p < 0.05). Compared to the reduced-core strategies, a full systematic saturation biopsy resulted in change to the focal therapy treatment plan in 12% (2/3 cores), 19% (1/2 cores), 24% (1/3 cores) and 29% (1/4 cores) of the time (p = 0.0434). CONCLUSIONS: Reducing the number of systematic biopsies when performing an MRI-targeted biopsy leads to reduced detection of csPCa and alter the treatment plans for focal therapy, possibly limiting its oncological efficacy.
引用
- Lee AYM, Chen K, Tan YG, et al. Reducing the number of systematic biopsy cores in the era of MRI targeted biopsy-implications on clinically-significant prostate cancer detection and relevance to focal therapy planning. Prostate Cancer Prostatic Dis. 2022. PMID: 35027690. doi:10.1038/s41391-021-00485-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。